查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1888649

醫療保健合約銷售組織市場規模、佔有率和趨勢分析報告：按服務、治療領域、最終用途、地區和細分市場預測（2025-2033 年）

Healthcare Contract Sales Organizations Market Size, Share & Trends Analysis Report By Service (Personal Promotion), By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

醫療保健合約銷售組織市場摘要

2024年全球醫療保健合約銷售組織市場規模估計為112.1億美元，預計到2033年將達到218.1億美元。

預計從 2025 年到 2033 年，該市場將以 7.87% 的複合年成長率成長。推動該市場成長的因素有很多，包括對專科和創新藥物的需求不斷成長、技術進步和數位轉型，以及醫療保健公司越來越重視擴大產品分銷管道。

全球醫療市場正朝著個人化和專業化方向發展，包括生物製藥、癌症治療和罕見疾病藥物，這是推動市場成長的因素之一。滿足創新藥物的需求需要一支訓練有素、專注於特定領域的銷售團隊。因此，製藥公司依靠具備專業治療知識和先進溝通能力的臨床負責人（CSO）來有效地向醫療專業人員傳達複雜的產品訊息。這使得CSO的職責範圍擴大到教育和宣傳活動、上市後支援以及數位互動等領域。

此外，人工智慧 (AI)、客戶關係管理 (CRM) 工具和數位行銷平台的整合正在徹底改變醫療保健產業的銷售營運和推廣績效。例如，約 35% 的製藥企業正在積極推動更廣泛的數位轉型 (DX)舉措，以提高效率和創新能力。掌握這些技術的首席銷售長 (CSO) 可以提供數據驅動的洞察，最佳化銷售團隊的生產力，並透過多通路策略增強客戶參與。這種數位化轉型降低了成本並提高了效率，使 CSO 成為現代製藥公司不可或缺的合作夥伴。此外，虛擬推廣和分析驅動型目標定位的應用，拓展了 CSO 的角色，使其超越了傳統的銷售營運，從而鞏固了其在日益技術驅動的醫療保健生態系統中的地位。

此外，全球醫療保健和製藥行業日益激烈的競爭促使企業尋求創新策略，以擴大產品覆蓋範圍並最大限度地提高收入潛力。隨著新的治療方法和醫療技術進入市場，醫療保健公司面臨著在各種醫療保健系統中實現快速推廣和廣泛應用的壓力。這導致與合約銷售組織 (CSO) 的合作激增，CSO 提供專業且擴充性的銷售團隊以及強大的本地市場洞察力。 CSO 幫助企業進入競爭激烈的市場，提高產品知名度，並與醫療保健專業人員保持持續互動。因此，醫療保健公司日益重視以銷售主導的舉措，持續推動全球對合約銷售服務的需求。

目錄

第1章調查方法和範圍

第2章執行摘要

3. 醫療保健合約銷售組織市場變數、趨勢和範圍

  • 市場譜系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 科技趨勢
  • 定價模式分析
  • 關稅影響分析
  • 市場分析工具
    • 波特五力分析
    • PESTEL 分析與 SWOT 分析

第4章：醫療保健合約銷售組織市場：按服務分類的估算和趨勢分析

  • 醫療保健合約銷售組織市場：按服務類型分類的波動分析
  • 醫療保健合約銷售組織市場按服務分類的估算和預測，2021-2033年
  • 個人晉升
    • 促銷銷售團隊
    • 重點客戶管理
    • 職缺管理
  • 非個人推廣
    • 醫療事務解決方案
    • 遠端醫療科學聯絡員
    • 護理師（臨床）負責人
    • 其他

第5章：醫療保健合約銷售組織市場：按治療領域分類的估算和趨勢分析

  • 醫療保健合約銷售組織市場：按治療領域分類的波動分析
  • 2021-2033年按治療領域分類的醫療保健合約銷售組織市場估算與預測
  • 腫瘤學
  • 循環系統疾病
  • 神經病學
  • 感染疾病
  • 代謝性疾病
  • 整形外科疾病
  • 其他

第6章：醫療保健合約銷售組織市場：依最終用途分類的估算與趨勢分析

  • 醫療保健合約銷售組織市場：按最終用途分類的差異分析
  • 醫療保健合約銷售組織市場按最終用途分類的估算和預測，2021-2033年
  • 製藥公司
  • 生物製藥公司
  • 醫療設備製造商

第7章：醫療保健合約銷售組織市場：區域估算與趨勢分析

  • 區域市場概覽
  • 區域市場佔有率分析（2024 年和 2033 年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 科威特
    • 卡達
    • 阿曼

第8章 競爭情勢

  • 主要參與企業分類
  • 2024年市場佔有率/評估分析（熱力圖分析）
  • 公司簡介
    • CMIC HOLDINGS Co., LTD.
    • Axxelus
    • EPS Corporation.
    • IQVIA Inc.
    • Publicis Group
    • MaBico
    • Syneos Health.
Product Code: GVR-4-68040-042-5

Healthcare Contract Sales Organizations Market Summary

The global healthcare contract sales organizations market size was estimated at USD 11.21 billion in 2024 and is projected to reach USD 21.81 billion by 2033, growing at a CAGR of 7.87% from 2025 to 2033. The market is advancing due to several factors, including the growing demand for specialty and innovative drugs, technological advancements and digital transformation, and the increasing interest of healthcare companies in expanding product sales.

Increasing global shift toward personalized and specialty medicines such as biologics, oncology therapies, and rare disease treatments is one of the factors driving market growth. Meeting the demand for innovative medicines requires highly trained, niche-focused salesforces. Thus, pharmaceutical companies rely on CSOs with specialized therapeutic knowledge and advanced engagement capabilities to effectively communicate complex product information to healthcare professionals. This has led to expanded roles for CSOs in educational outreach, post-launch support, and digital engagement.

Furthermore, the integration of artificial intelligence (AI), customer relationship management (CRM) tools, and digital marketing platforms is revolutionizing performance in healthcare sales and outreach. For instance, about 35% of drug manufacturers are adopting broader digital transformation initiatives to boost efficiency and innovation. CSOs adopting these technologies can deliver data-driven insights, optimize field force productivity, and enhance customer engagement through multichannel strategies. This digital transformation reduces costs and improves efficiency, making CSOs indispensable partners for modern pharmaceutical companies. Moreover, the use of virtual detailing and analytics-driven targeting has expanded the role of CSOs beyond traditional sales, strengthening their position in an increasingly tech-enabled healthcare ecosystem.

Moreover, intensifying competition in the global healthcare and pharmaceutical sectors has propelled companies to seek innovative strategies to expand their product reach and maximize revenue potential. As new therapies and medical technologies enter the market, healthcare firms face increasing pressure to achieve faster adoption and wider coverage across diverse healthcare systems. This has led to a surge in partnerships with contract sales organizations that offer specialized, scalable salesforces and strong local market expertise. CSOs help companies penetrate competitive markets, improve product visibility, and maintain consistent engagement with healthcare professionals. Thus, the growing sales-driven focus of healthcare firms continues to propel the demand for contract sales services worldwide.

Global Healthcare Contract Sales Organizations Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global healthcare contract sales organizations market report based on service, therapeutic area, end use, and region:

  • Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Personal Promotion
    • Promotional sales team
    • Key account management
    • Vacancy Management
  • Non - Personal Promotion
    • Medical Affairs Solutions
    • Remote Medical Science Liaisons
    • Nurse (Clinical) Educators
    • Others
  • Therapeutic Area Outlook (Revenue, USD Million, 2021 - 2033)
  • Oncology
  • Cardiovascular
  • Neurology
  • Infectious Diseases
  • Metabolic Disorders
  • Orthopedic Diseases
  • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Pharmaceutical companies
  • Biopharmaceutical companies
  • Medical device companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
    • Qatar
    • Oman

Table of Contents

Chapter 1. Research Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Service
    • 1.2.2. Therapeutic Area
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
    • 1.7.2. Top-Down Analysis
    • 1.7.3. Botton-Up Approach
    • 1.7.4. Multivariate Analysis
  • 1.8. List Of Secondary Sources
  • 1.9. List Of Abbreviations
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Healthcare Contract Sales Organizations Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing Demand for Specialty and Innovative Drug
      • 3.2.1.2. Technological Advancements and Digital Transformation
      • 3.2.1.3. Growing Interest of Healthcare Companies to Increase the Sales of the Products
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High Operational Costs
      • 3.2.2.2. Regulatory Complexity
  • 3.3. Technology Landscape
  • 3.4. Pricing Model Analysis
  • 3.5. Tariff Impact Analysis
  • 3.6. Market Analysis Tools
    • 3.6.1. Porter's Five Forces Analysis
    • 3.6.2. PESTEL by SWOT Analysis

Chapter 4. Healthcare Contract Sales Organizations Market: Service Estimates & Trend Analysis

  • 4.1. Healthcare Contract Sales Organizations Market, By Service: Segment Dashboard
  • 4.2. Healthcare Contract Sales Organizations Market, By Service: Movement Analysis
  • 4.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million)
  • 4.4. Personal Promotion
    • 4.4.1. Personal Promotion Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Promotional Sales Team
      • 4.4.2.1. Promotional Sales Team Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Key Account Management
      • 4.4.3.1. Key Account Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.4.4. Vacancy Management
      • 4.4.4.1. Vacancy Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Non-Personal Promotion
    • 4.5.1. Non - Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Medical Affairs Solutions
      • 4.5.2.1. Medical Affairs Solutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Remote Medical Science Liaisons
      • 4.5.3.1. Remote Medical Science Liaisons Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Nurse (Clinical) Educators
      • 4.5.4.1. Nurse (Clinical) Educators Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Healthcare Contract Sales Organizations Market: Therapeutic Area Estimates & Trend Analysis

  • 5.1. Healthcare Contract Sales Organizations Market, By Therapeutic Area: Segment Dashboard
  • 5.2. Healthcare Contract Sales Organizations Market, By Therapeutic Area: Movement Analysis
  • 5.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By Therapeutic Area, 2021 - 2033 (USD Million)
  • 5.4. Oncology
    • 5.4.1. Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Cardiovascular Diseases
    • 5.5.1. Cardiovascular Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Neurology
    • 5.6.1. Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Infectious Diseases
    • 5.7.1. Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Metabolic Disorders
    • 5.8.1. Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.9. Orthopedic Diseases
    • 5.9.1. Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Healthcare Contract Sales Organizations Market: End Use Estimates & Trend Analysis

  • 6.1. Healthcare Contract Sales Organizations Market, By End Use: Segment Dashboard
  • 6.2. Healthcare Contract Sales Organizations Market, By End Use: Movement Analysis
  • 6.3. Healthcare Contract Sales Organizations Market Estimates & Forecasts, By End Use, 2021 - 2033 (USD Million)
  • 6.4. Pharmaceutical companies
    • 6.4.1. Pharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Biopharmaceutical companies
    • 6.5.1. Biopharmaceutical companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Medical device companies
    • 6.6.1. Medical device companies Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Healthcare Contract Sales Organizations Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2033
  • 7.3. North America
    • 7.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. U.S
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Framework
      • 7.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Framework
      • 7.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Mexico
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Framework
      • 7.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.2. UK
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. Regulatory Framework
      • 7.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.3. Germany
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Regulatory Framework
      • 7.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.4. France
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Regulatory Framework
      • 7.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.5. Italy
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Competitive Scenario
      • 7.4.5.3. Regulatory Framework
      • 7.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.6. Spain
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Competitive Scenario
      • 7.4.6.3. Regulatory Framework
      • 7.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.7. Denmark
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Competitive Scenario
      • 7.4.7.3. Regulatory Framework
      • 7.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.8. Sweden
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Competitive Scenario
      • 7.4.8.3. Regulatory Framework
      • 7.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.4.9. Norway
      • 7.4.9.1. Key Country Dynamics
      • 7.4.9.2. Competitive Scenario
      • 7.4.9.3. Regulatory Framework
      • 7.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.2. Japan
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.3. China
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.4. India
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.5. Australia
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Regulatory Framework
      • 7.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Regulatory Framework
      • 7.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.5.7. South Korea
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.2. Brazil
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. Middle East & Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.4. Saudi Arabia
      • 7.7.4.1. Key Country Dynamics
      • 7.7.4.2. Competitive Scenario
      • 7.7.4.3. Regulatory Framework
      • 7.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.5. Kuwait
      • 7.7.5.1. Key Country Dynamics
      • 7.7.5.2. Competitive Scenario
      • 7.7.5.3. Regulatory Framework
      • 7.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.6. Qatar
      • 7.7.6.1. Key Country Dynamics
      • 7.7.6.2. Competitive Scenario
      • 7.7.6.3. Regulatory Framework
      • 7.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.7.7. Oman
      • 7.7.7.1. Key Country Dynamics
      • 7.7.7.2. Competitive Scenario
      • 7.7.7.3. Regulatory Framework
      • 7.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Key Participant Categorization
    • 8.1.1. Market Leaders
    • 8.1.2. Emerging Players
  • 8.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
  • 8.3. Company Profiles
    • 8.3.1. CMIC HOLDINGS Co., LTD.
      • 8.3.1.1. Company Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Service Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Axxelus
      • 8.3.2.1. Company Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Service Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. EPS Corporation.
      • 8.3.3.1. Company Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Service Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. IQVIA Inc.
      • 8.3.4.1. Company Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Service Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Publicis Group
      • 8.3.5.1. Company Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Service Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. MaBico
      • 8.3.6.1. Company Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Service Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Syneos Health.
      • 8.3.7.1. Company Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Service Benchmarking
      • 8.3.7.4. Strategic Initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 4. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 5. Global Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 6. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 7. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 8. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 9. North America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 10. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 11. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 12. U.S. Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 13. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 14. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 15. Canada Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 16. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 17. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 18. Mexico Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 19. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 20. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 21. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 22. Europe Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 23. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 24. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 25. UK Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 26. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 27. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 28. Germany Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 29. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 30. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 31. France Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 32. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 33. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 34. Italy Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 35. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 36. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 37. Spain Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 38. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 39. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 40. Denmark Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 41. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 42. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 43. Sweden Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 44. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 45. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 46. Norway Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 51. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 52. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 53. Japan Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 54. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 55. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 56. China Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 57. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 58. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 59. India Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 60. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 61. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 62. Australia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 63. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 64. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 65. Thailand Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 66. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 67. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 68. South Korea Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 69. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 70. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 71. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 72. Latin America Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 73. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 74. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 75. Brazil Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 76. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 77. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 78. Argentina Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 79. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million)
  • Table 80. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 81. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 82. Middle East & Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 83. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 84. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 85. South Africa Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 86. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 89. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 90. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 91. UAE Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 92. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 95. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 96. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 97. Oman Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)
  • Table 98. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million)
  • Table 99. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by Therapeutic Area, 2021 - 2033 (USD Million)
  • Table 100. Qatar Healthcare Contract Sales Organizations Market Estimates and Forecasts, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Commodity flow analysis
  • Fig. 7 Value-chain-based sizing & forecasting
  • Fig. 8 QFD model sizing & forecasting
  • Fig. 9 Bottom-up approach
  • Fig. 10 Market snapshot
  • Fig. 11 Segment snapshot 1
  • Fig. 12 Segment snapshot 2
  • Fig. 13 Competitive landscape snapshot
  • Fig. 14 Parent market outlook, 2024 (USD Billion)
  • Fig. 15 Ancillary market outlook, 2024 (USD Billion)
  • Fig. 16 Healthcare Contract Sales Organizations Market Dynamics
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Healthcare Contract Sales Organizations Market: Service Outlook and Key Takeaways
  • Fig. 20 Healthcare Contract Sales Organizations Market: Service Movement Analysis
  • Fig. 21 Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Promotional Sales Team Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Key Account Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Vacancy Management Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Non - Personal Promotion Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Medical Affairs Solutions Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Remote Medical Science Liaisons Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Nurse (Clinical) Educators Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Others Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Healthcare Contract Sales Organizations Market: Therapeutic Area Outlook And Key Takeaways
  • Fig. 31 Healthcare Contract Sales Organizations Market: Therapeutic Area Movement Analysis
  • Fig. 32 Oncology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Cardiovascular Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Neurology Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Infectious Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Metabolic Disorders Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Orthopedic Diseases Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Healthcare Contract Sales Organizations Market: End Use Outlook And Key Takeaways
  • Fig. 40 Healthcare Contract Sales Organizations Market: End Use Movement Analysis
  • Fig. 41 Pharmaceutical Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Biopharmaceutical Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Medical Device Companies Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Regional Marketplace: Key Takeaways
  • Fig. 45 North America Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021-2033 (USD Million)
  • Fig. 46 Key Country Dynamics
  • Fig. 47 U.S. Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Key Country Dynamics
  • Fig. 49 Canada Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Key Country Dynamics
  • Fig. 51 Mexico Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Europe Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key Country Dynamics
  • Fig. 54 UK Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key Country Dynamics
  • Fig. 56 Germany Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key Country Dynamics
  • Fig. 58 France Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key Country Dynamics
  • Fig. 60 Italy Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key Country Dynamics
  • Fig. 62 Spain Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key Country Dynamics
  • Fig. 64 Denmark Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key Country Dynamics
  • Fig. 66 Sweden Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key Country Dynamics
  • Fig. 68 Norway Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Asia Pacific Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key Country Dynamics
  • Fig. 71 Japan Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key Country Dynamics
  • Fig. 73 China Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key Country Dynamics
  • Fig. 75 India Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key Country Dynamics
  • Fig. 77 Australia Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key Country Dynamics
  • Fig. 79 Thailand Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key Country Dynamics
  • Fig. 81 South Korea Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Latin America Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Key Country Dynamics
  • Fig. 84 Brazil Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key Country Dynamics
  • Fig. 86 Argentina Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 87 Middle East & Africa Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key Country Dynamics
  • Fig. 89 South Africa Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Key Country Dynamics
  • Fig. 91 UAE Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 92 Key Country Dynamics
  • Fig. 93 Saudi Arabia Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 94 Key Country Dynamics
  • Fig. 95 Kuwait Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 96 Key Country Dynamics
  • Fig. 97 Qatar Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)
  • Fig. 98 Key Country Dynamics
  • Fig. 99 Oman Healthcare Contract Sales Organizations Market Estimates And Forecasts, 2021 - 2033 (USD Million)